REQUEST A DEMO
Total
USD $0.00
Search more companies

Enzychem Lifesciences Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Enzychem Lifesciences Corporation Profile Updated: July 04, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Enzychem Lifesciences Corporation is engaged in developing, produces, and markets active pharmaceutical ingredients (APIs) and functional health foods. The company is also developing drugs to treat chemotherapy-induced neutropenia and thrombocytopenia, sepsis, cancers, and autoimmune disorders. Its APIs primarily comprise D-Cycloserine and Terizidone that are used to treat tuberculosis; antibiotics in the family of cephalosporin, such as Cefbuperazone and Cefazedone; and other APIs for anti-coagulant and anti-inflammatory analgesic drugs. Enzychem Lifesciences Corporation exports its APIs for antibiotics and cosmetic ingredients to Japan, India, Pakistan, Russia, the CIS countries, the United Kingdom, Germany, Peru, Thailand, Taiwan, Malaysia, and other countries. The company was founded in 1999 and is headquartered in Daejeon, South Korea.

Headquarters
59, Bio valley-ro Jecheon-si Chungbuk
Jecheon; Chungcheongbuk;

Contact Details: Purchase the Enzychem Lifesciences Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Outstanding Shares:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Registered Capital:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Incorporation Date:
July 20, 1999
Key Executives
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
12.3%
Purchase this report to view the information.
7.4%
Purchase this report to view the information.
0.7%
Company Performance
Financial values in the chart are available after Enzychem Lifesciences Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
15.94%
Total operating revenue
15.94%
Operating profit (EBIT)
30.46%
EBITDA
34.9%
Net Profit (Loss) for the Period
11.73%
Total assets
86.1%
Total equity
171.32%
Operating Profit Margin (ROS)
36.31%
Net Profit Margin
29.32%
Return on Equity (ROE)
25.65%
Debt to Equity Ratio
0.77%
Quick Ratio
3.1%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?